Conjugated linoleic acid (CLA) versus saturated fats/cholesterol: their proportion in fatty and lean meats may affect the risk of developing colon cancer

Lipids in Health and Disease

Cristina B Lopez¹  Aldo R Eynard¹ 

[1] Instituto de Biología Celular, Cátedra de Histología, FCM-UNC/CONICET. Casilla de Correos 220, 5000 Córdoba. ARGENTINA

关键词: PUFA;    essential fatty acids;    colon cancer;    cholesterol;    fats;    red meats;    CLA;   

Others  :  1213322
DOI  :  10.1186/1476-511X-2-6

 received in 2003-06-23, accepted in 2003-08-29,  发布年份 2003

【 摘 要 】

In spite of the considerable amount of experimental, clinical and epidemiological research about the consumption of red meat, total fats, saturated/unsaturated fatty acids and cholesterol with regard to the risk of developing colorectal cancer (CRC), the issue remains controversial. The general belief is a reduction of red meat intake, and subsequent nutritional advice usually strongly recommends this. Paradoxically, beef together with whole milk and dairy derivatives, are almost the only sources for conjugated linoleic acid (CLAs) family. Furthermore CLAs are the only natural fatty acids accepted by the National Academy of Sciences of USA as exhibiting consistent antitumor properties at levels as low as 0.25 – 1.0 per cent of total fats. Beside CLA, other polyunsaturated fatty acids (PUFA) belonging to the essential fatty acid (EFA) n-3 family, whose main source are fish and seafood, are generally believed to be antipromoters for several cancers. The purpose of this work is to critically analyze the epidemiological and experimental evidence by tentatively assuming that the reciprocal proportions of saturated fats (SA) plus cholesterol (CH) versus CLAs levels in fatty or lean beef may play an antagonistic role underlying the contradictory effects reported for red meats consumption and CRC risk. Recent results about meat intake and risk for CRC in Argentina have shown an unexpected dual behaviour related to the type of meats. Fatty meat derivatives, such as cold cuts and sausages, mainly prepared from fatty beef (up to 37% fat) were associated with higher risk, whereas high consumption of lean beef (< 15% fat) behaved as a protective dietary habit. CLA is located in the interstitial, non-visible, fat evenly distributed along muscle fibres as well as in subcutaneous depots. Visible fat may be easily discarded during the meal, whereas interstitial fats will be eaten. The remaining intramuscular fat in lean meats range from 25 to 50 g/Kg (2.5 to 5%). The proportion of CLA/SA+CH for lean beef eaters is 0.09 and the fatty mets 0.007 (g/100 g). As a consequence, the beneficial effects of minor amounts of CLA may be relatively enhanced in lean meat compared to fatty meat sub-products which contain a substantial amount of saturated fatty acids and cholesterol, as in cold cuts and cow viscera.

【 授权许可】

   
2003 Eynard and Lopez; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 参考文献 】

• [1]De Lany JP, West DB: Changes in body composition with conjugated linoleic acid. J Am Coll Nutr 2000, 19:487S-493S.
• [2]Rudel LL: Atheroesclerosis and conjugated linoleic acid. B J Nutr 1999, 81:177-179.
• [3]Ha YL, Storkson J, Pariza MW: Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivarives of linoleic acid. Cancer Res 1990, 50:1097-101.
• [4]National Research Council (NRC): Carcinogens and anticarcinogens in the human diet. National Academy Press, Washington DC; 1996.
• [5]Navarro A, Osella AR, Muñoz SE, Lantieri MJ, Fabro EA, Eynard AR: Fatty acids, fibres and colorectal cancer risk in Córdoba, Argentina. J Epidemiol and Biostatistics 1998, 3:415-422.
• [6]Navarro A, Diaz M, Muñoz S, Lantieri Maria, Eynard AR: Characterization of meat consumption and risk of colorectal cancer in Cordoba, Argentina. Nutrition 2003, 19:7-10.
• [7]Crespi M: Models of screening program for colorectal cancer. Med Arch 2002, 56:47-49.
• [8]Navarro A, Muñoz SE, Eynard AR: Diet feeding habits and risk of colorectal cancer in Córdoba, Argentina. A pilot study. J Exp Clin Cancer Res 1995, 14:287-291.
• [9]Mc Lellan EA, Bird RP: Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res 1998, 48:6183-6186.
• [10]Sesink AL, Termont DS, Kleibeuker JH, Van Der Meer: Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. Carcinogenesis 2000, 21:1909-1915.
• [11]Eynard AR: Does chronic essential fatty acid deficiency (EFAD) constitute a pro-tumorigenic condition ? Med Hypotheses 1997, 48:55-62.
• [12]Moloney AP, Mooney MT, Kerry JP, Troy DJ: Producing tender and flavoursome beef with enhanced nutritional characteristics. Proc Nutr Soc 2001, 60:221-229.
• [13]Mc Donald HB: Conjugated linoleic acids and disease prevention: a review of current knowledge. B J AM Coll Nutr 2000, 19(2 Suppl):111S-118S.
• [14]Navarro A, Muñoz SE, Lantieri MJ, Fabro EA, Eynard AR: Composición de acidos grasos saturados e insaturados en alimentos de uso frecuente en Argentina. Archivos Lat de Nutr 1997, 47:276-281.
• [15]Ma DW, Wierzbicki AA, Field CJ, Clandinin MT: Conjugated linoleic acids in Canadian dairy and beef products. J Agric Food Chem 1999, 47:1956-1960.
• [16]Kelly Gregory S: Conjugated linoleic acids: a review. J Alternative Med Rev 2001, 6:367-383.
• [17]Gonzales M, Riordan NH, Riordan HD: Antioxidants as chemopreventive agents for breast cancer. Biomedicina 1998, 1:120-127.
• [18]Pariza MW, Park Y, Cook ME: The biologically active isomers of conjugated linoleic acids. Prog Lipid Res 2001, 40:283-298.
• [19]French P, Stanton C, Lawless F, O'Riordan EG, Monahan FJ, Caffrey PJ, Moloney AP: Fatty acid composition, including conjugated linoleic acid, of intramuscular fat from steers offered grazed grass, grass silage, or concentrate-based diets. J Anim Sci 2000, 78:2849-2855.
• [20]West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J: Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 1998, 275(3Pt2):R667-672.
• [21]Kelly ML, Berry JR, Dwyer DA, Griinari JM, Chouinard PY, Van Amburgh ME, Bauman DE: Dietary fatty acid sources affect conjugated linoleic acid concentrations in milk from lactating dairy cows. J Nutr 1998, 128:881-885.
• [22]Dhiman TR, Satter LD, Pariza MW, Galli MP, Albright K, Tolosa MX: Conjugated linoleic acid (CLA) content of milk from cows offered diets rich in linolenic acid. J Dairy Sci 2000, 83:1016-1027.
• [23]Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH: Protection of conjugated linoleic acid against 2-amino-3-methylimidazol [4,5-f] quinolone-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanism. Carcinogenesis 1995, 16:3037-3043.
• [24]Ip C, Scimeca JA, Thompson H: Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer 1994, 74(3 Suppl):1050-1054.
• [25]Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T: Dietary conjugated linoleic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 2002, 93:133-142.
• [26]Park HS, Ryu JH, Ha YL, Park JH: Dietary conjugated linoleic acid induces apoptosis of colonic mucosa in 1. 2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 2001, 86(5):549-555.
• [27]Parodi PW: Cow's milk fat components as potential anticarcinogenic agents. J Nutr 1997, 127:1055-1060.
• [28]Shultz TD, Chew BP, Seaman WR, Luedecke LO: Inhibitory effect of conjugated dienoic derivates of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett 1992, 15(63):125-133.
• [29]O'Shea M, Devery R, Lawless F, Murphy J, Stanton C: Milk fat conjugated linoleic acid (CLA) inhibits growth of human mammary MCF-7 cancer cells. Anticancer Res 2000, 20:3591-3601.
• [30]Giovannucci E, Goldin B: The role of fat, fatty acids and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 1997, 66:1564-1571.
• [31]Hill MJ: Mechanisms of diet and colon carcinogenesis. Eur J Cancer Prev 1999, Suppl 1:S95-98.
• [32]Pfeuffer M, Schrezenmeir J: Bioactive substances in milk with properties decreasing risk of cardiovascular disease. Br J Nutr 2000, Suppl 1:S155-159.
• [33]Parodi PW: Cow's milk fat components as potential anticancinogenic agents. Am Soc Nutr Sci 1997, 1055-1059.
• [34]Eynard AR: Potential of essential fatty acids as natural therapeutic products for human tumors. Nutrition 2003, 19:386-388.